CD8A and melanoma: However, vaccination with autologous pDCs, in patients with melanoma results in higher levels of chemokines attracting cytotoxic T-lymphocytes (CD8 T-cells, or γδ T-cells) compared to that with cDC2s (although a response is also observed with this strategy) [163].